Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
VR ADVISER, LLC (CIK 1615982) reported $2.68B across 33 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: APGE ($714.9M, 26.68%), ERAS ($265.1M, 9.89%), ORKA ($203.5M, 7.60%), SYRE ($185.9M, 6.94%), KALV ($130.3M, 4.86%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | APGE | APOGEE THERAPEUTICS INC | $714.9M | 26.68% | 8.5M | Hold |
| 2 | ERAS | ERASCA INC | $265.1M | 9.89% | 16.4M | Trimmed |
| 3 | ORKA | ORUKA THERAPEUTICS INC | $203.5M | 7.60% | 4.1M | Hold |
| 4 | SYRE | SPYRE THERAPEUTICS INC | $185.9M | 6.94% | 3.7M | Hold |
| 5 | KALV | KALVISTA PHARMACEUTICALS INC | $130.3M | 4.86% | 6.5M | Trimmed |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | $99.0M | 3.70% | 1.2M | Added |
| 7 | GLTO | DAMORA THERAPEUTICS INC | $93.3M | 3.48% | 3.6M | New |
| 8 | OCUL | OCULAR THERAPEUTIX INC | $87.6M | 3.27% | 10.3M | Added |
| 9 | COGT | COGENT BIOSCIENCES INC | $77.0M | 2.87% | 2.0M | Hold |
| 10 | VRDN | VIRIDIAN THERAPEUTICS INC | $75.9M | 2.83% | 3.9M | Hold |
| 11 | SVRA | SAVARA INC | $75.0M | 2.80% | 13.7M | Hold |
| 12 | ELVN | ENLIVEN THERAPEUTICS INC | $67.7M | 2.53% | 1.7M | Trimmed |
| 13 | ORIC | ORIC PHARMACEUTICALS INC | $54.7M | 2.04% | 4.3M | Trimmed |
| 14 | VOR | VOR BIOPHARMA INC | $54.3M | 2.03% | 3.0M | Added |
| 15 | MAZE | MAZE THERAPEUTICS INC | $47.8M | 1.78% | 1.6M | Added |
| 16 | CTMX | CYTOMX THERAPEUTICS INC | $46.9M | 1.75% | 10.0M | Trimmed |
| 17 | JBIO | JADE BIOSCIENCES INC | $45.2M | 1.69% | 3.2M | Hold |
| 18 | DYN | DYNE THERAPEUTICS INC | $39.4M | 1.47% | 2.2M | Hold |
| 19 | CBIO | CRESCENT BIOPHARMA INC. | $39.2M | 1.46% | 2.1M | Hold |
| 20 | ZURA | ZURA BIO LTD | $38.3M | 1.43% | 6.4M | Added |
| 21 | RLMD | RELMADA THERAPEUTICS INC | $33.7M | 1.26% | 4.8M | New |
| 22 | ENGN | ENGENE HOLDINGS INC | $32.5M | 1.21% | 4.8M | Hold |
| 23 | TENX | TENAX THERAPEUTICS INC | $26.8M | 1.00% | 1.7M | New |
| 24 | ANL | ADLAI NORTYE LTD | $22.2M | 0.83% | 3.2M | New |
| 25 | CGEM | CULLINAN THERAPEUTICS INC | $19.6M | 0.73% | 1.4M | Hold |
Source: SEC Form 13F filings · as of 2026-03-31